{"id":950090,"date":"2026-04-09T06:10:24","date_gmt":"2026-04-09T10:10:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/"},"modified":"2026-04-09T06:10:24","modified_gmt":"2026-04-09T10:10:24","slug":"adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/","title":{"rendered":"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p>\nADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law<\/p>\n<p>\nBFA Law is investigating ADMA Biologics after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws.<\/p>\n<p>NEW YORK&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nLeading securities law firm <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;esheet=54486774&amp;newsitemid=20260409617448&amp;lan=en-US&amp;anchor=Bleichmar+Fonti+%26amp%3B+Auld+LLP&amp;index=1&amp;md5=d2f7b664a0aa7a90540818cd42c5c459\"><b>Bleichmar Fonti &amp; Auld LLP<\/b><\/a> announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws.<\/p>\n<p>\nIf you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;esheet=54486774&amp;newsitemid=20260409617448&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;index=2&amp;md5=f378f1222366a80c1e0c30822969954e\"><b>https:\/\/www.bfalaw.com\/cases\/adma-biologics-class-action-lawsuit<\/b><\/a>.<\/p>\n<p><b>Why is ADMA Biologics Being Investigated for Securities Fraud?<\/b><\/p>\n<p>\nADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing and developing specialty biologics. ADMA Biologics\u2019 flagship product is ASCENIV, a liquid immune globulin solution used to treat Primary Humoral Immunodeficiency in adults and adolescents.<\/p>\n<p>\nBFA is investigating allegations that ADMA Biologics\u2019 reported 20% revenue growth in 2025 was driven by a channel stuffing scheme to mask deteriorating demand.<\/p>\n<p><b>Why did ADMA Biologics\u2019 Stock Drop?<\/b><\/p>\n<p>\nOn March 24, 2026, Culper Research, an investigative research firm, published a report titled \u201cADMA Biologics Inc (ADMA): Channel Stuffing, an Undisclosed Related Party Distributor, and \u20133% Real Growth in 2025 vs. +20% Reported.\u201d The report revealed, among other things, that in 2025 ADMA Biologics induced one of its distributors to \u201cstock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations.\u201d This allegedly allowed ADMA Biologics to book revenue and \u201creport[] growth that was never there.\u201d According to Culper Research, had ADMA Biologics not engaged in this alleged channel stuffing scheme, it would have experienced revenue declines of 3% in 2025 instead of the reported 20% growth.<\/p>\n<p>\nThis news caused the price of ADMA Biologics stock to decline $3.96 per share, or 29%, over the course of two trading days, from $13.59 per share on March 23, 2026, to $9.63 per share on March 25, 2026.<\/p>\n<p><b>Click here for more information: <\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;esheet=54486774&amp;newsitemid=20260409617448&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;index=3&amp;md5=cd0eb7e968185433a1bfc8c40f64d8db\"><b>https:\/\/www.bfalaw.com\/cases\/adma-biologics-class-action-lawsuit<\/b><\/a><b>.<\/b><\/p>\n<p><b>What Can You Do?<\/b><\/p>\n<p>\nIf you invested in ADMA Biologics, you may have legal options and are encouraged to submit your information to the firm.<\/p>\n<p>\nAll representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.<\/p>\n<p><b>Submit your information by visiting:<\/b><\/p>\n<p class=\"bwalignc\"><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;esheet=54486774&amp;newsitemid=20260409617448&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;index=4&amp;md5=127d55edbd6a367aed86bc9449d9151c\"><b>https:\/\/www.bfalaw.com\/cases\/adma-biologics-class-action-lawsuit<\/b><\/a><\/p>\n<p>\nOr contact:<br \/>\n<br \/>Adam McCall<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:adam@bfalaw.com\">adam@bfalaw.com<br \/>\n<\/a><br \/>212.789.3619<\/p>\n<p><b>Why Bleichmar Fonti &amp; Auld LLP?<\/b><\/p>\n<p>\nBFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by <i>Chambers USA<\/i>, <i>The Legal 500<\/i>, and <i>ISS SCAS<\/i>, and its attorneys have been named \u201cElite Trial Lawyers\u201d by the <i>National Law Journal<\/i>, \u201cLitigation Stars\u201d by <i>Benchmark Litigation<\/i>, among the top \u201c500 Leading Plaintiff Financial Lawyers\u201d by <i>Lawdragon<\/i>, \u201cTitans of the Plaintiffs\u2019 Bar\u201d by <i>Law360<\/i> and \u201cSuperLawyers\u201d by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.\u2019s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.<\/p>\n<p>\nFor more information about BFA and its attorneys, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com&amp;esheet=54486774&amp;newsitemid=20260409617448&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com&amp;index=5&amp;md5=5bb3ccb9c9379d60060d67d73ae43ffd\">https:\/\/www.bfalaw.com<\/a>.<\/p>\n<p class=\"bwalignc\"><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;esheet=54486774&amp;newsitemid=20260409617448&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.bfalaw.com%2Fcases%2Fadma-biologics-class-action-lawsuit&amp;index=6&amp;md5=6a20baf80c3719eaf32c4da5d7fc4b15\"><b>https:\/\/www.bfalaw.com\/cases\/adma-biologics-class-action-lawsuit<\/b><\/a><\/p>\n<p><i>Attorney advertising. Past results do not guarantee future outcomes.<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409617448r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260409617448\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260409617448\/en\/<\/a><\/span><\/p>\n<p>\nAdam McCall<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:adam@bfalaw.com\">adam@bfalaw.com<br \/>\n<\/a><br \/>212.789.3619<\/p>\n<p><b>KEYWORDS:<\/b> New York United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Class Action Lawsuit Professional Services Legal<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260409617448\/en\/2769225\/3\/BFA_Law_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law BFA Law is investigating ADMA Biologics after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws. NEW YORK&#8211;(BUSINESS WIRE)&#8211; Leading securities law firm Bleichmar Fonti &amp; Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting: https:\/\/www.bfalaw.com\/cases\/adma-biologics-class-action-lawsuit. Why is ADMA Biologics Being Investigated for Securities Fraud? ADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing and developing specialty biologics. ADMA Biologics\u2019 flagship product is ASCENIV, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-950090","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law BFA Law is investigating ADMA Biologics after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws. NEW YORK&#8211;(BUSINESS WIRE)&#8211; Leading securities law firm Bleichmar Fonti &amp; Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting: https:\/\/www.bfalaw.com\/cases\/adma-biologics-class-action-lawsuit. Why is ADMA Biologics Being Investigated for Securities Fraud? ADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing and developing specialty biologics. ADMA Biologics\u2019 flagship product is ASCENIV, &hellip; Continue reading &quot;ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-09T10:10:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409617448r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law\",\"datePublished\":\"2026-04-09T10:10:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\\\/\"},\"wordCount\":586,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260409617448r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\\\/\",\"name\":\"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260409617448r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-04-09T10:10:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260409617448r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260409617448r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/","og_locale":"en_US","og_type":"article","og_title":"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law - Market Newsdesk","og_description":"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law BFA Law is investigating ADMA Biologics after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws. NEW YORK&#8211;(BUSINESS WIRE)&#8211; Leading securities law firm Bleichmar Fonti &amp; Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting: https:\/\/www.bfalaw.com\/cases\/adma-biologics-class-action-lawsuit. Why is ADMA Biologics Being Investigated for Securities Fraud? ADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing and developing specialty biologics. ADMA Biologics\u2019 flagship product is ASCENIV, &hellip; Continue reading \"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-09T10:10:24+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409617448r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law","datePublished":"2026-04-09T10:10:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/"},"wordCount":586,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409617448r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/","name":"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409617448r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-04-09T10:10:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409617448r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260409617448r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-fraud-notice-adma-biologics-investors-are-notified-the-company-is-being-investigated-for-securities-fraud-after-29-stock-drop-bfa-law\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop \u2014 BFA Law"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=950090"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950090\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=950090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=950090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=950090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}